Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Early Phase 1
1(25.0%)
4Total
N/A(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07182578Not ApplicableRecruiting

Programming Aquatic Therapy for POTS

Role: lead

NCT04601649Early Phase 1Unknown

PrEP Talk: PrEP Uptake With Young Black MSM and Their Close Friends

Role: lead

NCT02026570Not ApplicableUnknown

Enhancement of Residual Limb Proprioception and Rehabilitation Training Methods With a Vibrotactile Device.

Role: collaborator

NCT02924259Not ApplicableCompleted

Does Self-myofascial Release With a Foam Roll Change Pressure Pain Thresholds in Lower Extremity Muscles

Role: lead

NCT02806622Unknown

Comparison of Hip Range of Motion Values Among NCAA Division II Collegiate Athletes

Role: lead

NCT02802202Completed

Validation of a Pressure Pain Threshold Scale in Patients Diagnosed With Myofascial Pain Syndrome and Fibromyalgia

Role: lead

All 6 trials loaded